Patent US4973304A successfully refreshed from Google Patents.
US4973304A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Device for sustained release of active substance
Assignee: BTG International Ltd
•
Filing: 1990-02-07
•
Granted: 1990-11-27
•
Expires: 2010-02-07
Abstract
Abstract A device for the sustained release of active substance comprises a wall defining a cavity for the reception of active substance, the wall being of impermeable material and having one or more ports therethrough. Sections of hydrogel material are within the cavity, the hydrogel, in use, being swollen to cover the ports in the cavity wall. Active ingredient is released from the container only through the hydrogel covering the ports. In this way sustained and controlled release of the active substance from the device is obtained.
Inventors
- 👤 Neil B. Graham
- 👤 Ernst R. Huehns
- 👤 Marion E. McNeill
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-26 23:34
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0087; A61K9/0092; A61F; A61F6/00; A61F6/06; A61F6/08; A61K9/0012; A61K9/0019; A61K9/0024; A61K9/0034; A61K9/0036; A61M; A61M31/00; A61M31/002; A61M25/00; A61M25/0067
Claims Analysis
Total Claims: 18
Claim 1
Independent Claim
140 words
A sustained release device for releasing active substance from a cavity, when such cavity contains the active substance, through a layer of hydrogel extending across at least one port in a wall made of water-impermeable material, which device comprises: a container having a wall formed from a water-impermeable material, the wall having at least one port therethrough, and which wall defines the cavity for the reception of active substance; and within the container cavity, at least one body of hydrogel material, the hydrogel material, when in the dry state, being capable of being inserted into the container cavity and, when in the swollen condition, extending across the port or ports in the cavity wall and making sealing and pressing contact with the cavity wall adjacent the port or ports, said hydrogel material not being contiguous with the entire cavity wall.
Claim 2
Dependent Claim
140 words
A sustained release device for releasing active substance from a cavity, when such cavity contains the active substance, through a layer of hydrogel extending across at least one port in a wall made of water-impermeable material, which device comprises: a container having a wall formed from a water-impermeable material, the wall having at least one port therethrough, and which wall defines the cavity for the reception of active substance; and within the container cavity, at least one body of hydrogel material, the hydrogel material, when in the dry state, being capable of being inserted into the container cavity and, when in the swollen condition, extending across the port or ports in the cavity wall and making sealing and pressing contact with the cavity wall adjacent the port or ports, said hydrogel material not being contiguous with the entire cavity wall.
Claim 3
Dependent Claim
13 words
The device according to claim 1 wherein the wall is of flexible material.
Claim 4
Dependent Claim
28 words
The device according to claim 1 wherein the hydrogel material when in swollen condition contacts the cavity wall substantially only in the region of the port or ports.
Claim 5
Dependent Claim
25 words
The device according to claim 1 which is in the form of a rechargeable surgical implant device and wherein the wall is of self-sealing material.
Claim 6
Dependent Claim
44 words
The device according to claim 1 which is in the form of a rechargeable surgical implant device and which is provided with at least one releasable seal whereby active substance can be introduced into the cavity when the device is implanted in a patient.
Claim 7
Dependent Claim
54 words
The device according to claim 1 which comprises a tube of water-impermeable material, the tube wall having a plurality of ports along its length, which tube contains one or more annular sections of hydrogel material which when in swollen condition covers the ports in the tube wall, the tube being sealed at its ends.
Claim 8
Dependent Claim
18 words
The device according to claim 1, wherein said water-impermeable material of said wall is medical grade silicon rubber.
Claim 9
Dependent Claim
53 words
The device according to claim 1, wherein said hydrogel is a material selected from the group consisting of crosslinked poly(ethylene glycol or ethylene oxide), polyacrylamides, poly-N-vinylpyrrolidones, polyhydroxyethyl and -propyl(meth)acrylates, polyoxyethylated derivatives of said (meth)acrylates, crosslinked polyvinyl alcohols, crosslinked starches, dextrans, polyhydric natural products, polyacrylic acids, polymethacrylic acids, crosslinked proteins and crosslinked glutamic acid.
Claim 10
Dependent Claim
120 words
A sustained release device for releasing active substance from a cavity containing the active substance, through a layer of hydrogel extending across at least one port in a wall made of water-impermeable material, which device comprises: a container having a wall formed from a water-impermeable material, the wall having at least one port therethrough, and which wall defines the cavity which contains said active substance; and within the container cavity, at least one body of hydrogel material, when in the dry state, being capable of being inserted into the container cavity and, when in the swollen condition, making sealing contact with the cavity wall adjacent the port or ports, said hydrogel material not being contiguous with the entire cavity wall.
Claim 11
Dependent Claim
120 words
A sustained release device for releasing active substance from a cavity containing the active substance, through a layer of hydrogel extending across at least one port in a wall made of water-impermeable material, which device comprises: a container having a wall formed from a water-impermeable material, the wall having at least one port therethrough, and which wall defines the cavity which contains said active substance; and within the container cavity, at least one body of hydrogel material, when in the dry state, being capable of being inserted into the container cavity and, when in the swollen condition, making sealing contact with the cavity wall adjacent the port or ports, said hydrogel material not being contiguous with the entire cavity wall.
Claim 12
Dependent Claim
42 words
The device according to claim 9 wherein the active substance is present in the device in saturated solution or is present in such amount that on introduction of aqueous medium into the device a saturated solution of the active substance is formed.
Claim 13
Independent Claim
125 words
A method of administering active substance to a patient which method comprises implanting into or introducing into the patient's body a sustained release device for releasing active substance from a cavity containing the active substance through a layer of hydrogel covering at least one port in a wall made of water-impermeable material, wherein the wall defines the cavity and the cavity contains active substance and at least one body of hydrogel material which hydrogel material when in swollen condition is not contiguous with the entire cavity wall but covers the port or ports in the wall, and maintaining the hydrogel material in swollen condition, the active substance being released from the cavity through the hydrogel layer covering the port or ports into the patient's body.
Claim 14
Independent Claim
125 words
A method of administering active substance to a patient which method comprises implanting into or introducing into the patient's body a sustained release device for releasing active substance from a cavity containing the active substance through a layer of hydrogel covering at least one port in a wall made of water-impermeable material, wherein the wall defines the cavity and the cavity contains active substance and at least one body of hydrogel material which hydrogel material when in swollen condition is not contiguous with the entire cavity wall but covers the port or ports in the wall, and maintaining the hydrogel material in swollen condition, the active substance being released from the cavity through the hydrogel layer covering the port or ports into the patient's body.
Claim 15
Independent Claim
114 words
A method of treating thalassaemia which method comprises implanting into or introducing into a patient's body a sustained release device for releasing active substance from a cavity containing the active substance through a layer of hydrogel covering at least one port in a wall made of water-impermeable material, wherein the wall defines the cavity and the cavity contains desferrioxamine in aqueous solution and at least one body of hydrogel material which hydrogel material when in swollen condition is not contiguous with the entire cavity wall but covers the port or ports in the wall, the desferrioxamine being released from the cavity through the hydrogel layer covering the port or ports into the patient's body.
Claim 16
Independent Claim
114 words
A method of treating thalassaemia which method comprises implanting into or introducing into a patient's body a sustained release device for releasing active substance from a cavity containing the active substance through a layer of hydrogel covering at least one port in a wall made of water-impermeable material, wherein the wall defines the cavity and the cavity contains desferrioxamine in aqueous solution and at least one body of hydrogel material which hydrogel material when in swollen condition is not contiguous with the entire cavity wall but covers the port or ports in the wall, the desferrioxamine being released from the cavity through the hydrogel layer covering the port or ports into the patient's body.
Claim 17
Dependent Claim
18 words
The device according to claim 9, wherein said water-impermeable material of said wall is medical grade silicon rubber.
Claim 18
Dependent Claim
47 words
The device according to claim 9, wherein said hydrogel is a material selected from the group consisting of polyacrylamides, poly-N-vinylpyrrolidones, polyhydroxyethyl and -propyl(meth)acrylates, polyoxyethylated derivatives of said (meth)acrylates, crosslinked polyvinyl alcohols, crosslinked starches, dextrans, polyhydric natural products, polyacrylic acids, polymethacrylic acids, crosslinked proteins and crosslinked glutamic acid.
References Cited (Backward Citations)
US3093831A
Cited
US3896806A
Cited
US3796217A
Cited
US3971376A
Cited
US3946734A
Cited
US4220153A
Cited
US4814182A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1993-11-26 | 1994-05-28 | 1994-11-27 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1997-11-26 | 1998-05-28 | 1998-11-27 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2001-11-26 | 2002-05-28 | 2002-11-27 | $7700.00 | Window Closed / Lapsed |